Trials / Completed
CompletedNCT00534989
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | FDG PET | FDG PET |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2013-02-01
- Completion
- 2013-12-01
- First posted
- 2007-09-26
- Last updated
- 2015-12-17
Source: ClinicalTrials.gov record NCT00534989. Inclusion in this directory is not an endorsement.